A Conversation With Iryna Timanyuk
Iryna Timanyuk is a pharmaceutical scientist, international business analyst, and healthcare strategist with extensive experience in pharmaceutical sciences, nutraceuticals, and professional skincare. With a strong academic background as an Associate Professor and PhD specialist, she combines scientific expertise with global market insight to promote evidence-based wellness solutions. Her work focuses on preventive healthcare, microbiome-centered innovation, and bringing Japanese-inspired healthcare and skincare concepts to European and international markets through ethical, research-driven approaches.
Global Healthcare Leadership
We started the interview by asking, “You have a strong academic foundation in pharmaceutical sciences. How has your transition from academia to international business analysis shaped your perspective on healthcare today?”
Iryna Timanyuk replied, “My academic background taught me to approach healthcare with discipline, evidence and critical thinking. Working for many years at the National University of Pharmacy in Kharkiv as an Associate Professor (PhD in Pharmaceutical Sciences) gave me deep insight into pharmaceutical marketing, market analysis and the importance of scientific validation in every decision.
The war in Ukraine and my relocation to Lithuania became a turning point that pushed me to apply this knowledge in a very different context – international projects, cross‑cultural partnerships and real‑world challenges in nutraceuticals and professional skincare. Today, I see healthcare not only as a scientific field, but also as a space where education, accessibility, cultural understanding and responsible innovation must work together to improve people’s quality of life.”
Discovering the Science behind Nutraceutical Wellness
The Europe Time: You specialize in evidence-based nutraceuticals and Japanese-inspired wellness concepts. What attracted you to this field?
Iryna Timanyuk replied, “Coming from a strict pharmaceutical and academic environment, I was initially very skeptical about dietary supplements. For many years, I saw them as a weakly regulated category with too many promises and not enough evidence. My perspective started to change only after I encountered products supported by serious clinical research and strong scientific foundations, particularly within Japanese biotic technologies.
A key turning point for me was discovering Dr. Ohhira after relocating to Europe. Through studying its clinical data and related research, I realised that probiotics, postbiotics and fermented products act far beyond the digestive tract. By influencing the microbiome and the gut-brain axis, they are connected with immune response, metabolic regulation and many other physiological and neurological processes, which make their potential impact on the body remarkably extensive.
What attracted me most was the combination of scientific rigor, preventive healthcare philosophy and the holistic Japanese approach to wellbeing. We now apply the same mindset not only to nutraceuticals, but also to professional Japanese‑inspired skincare, bringing Japanese science and culture of care into products for European consumers.”
Cultures in Premium Healthcare Markets
The Europe Time: In your opinion, what are the biggest challenges when introducing premium healthcare and skincare products into European and Asian markets?
Iryna Timanyuk replied, “One of the biggest challenges is balancing scientific credibility with consumer expectations. Every market has different cultural perceptions, levels of awareness and habits when it comes to wellness products and skincare. Premium Japanese concepts often come with a long‑term, prevention‑oriented philosophy rather than “quick fixes”, and this sometimes requires careful explanation and adaptation for local audiences.
When we work with Japanese‑inspired nutraceuticals and professional skincare, my role is to help partners preserve the authenticity, quality and cultural roots of these products while making them understandable and relevant for local consumers. This includes, for example, introducing Sentaku products co‑created with Japanese manufacturers and adapting them to the expectations and realities of different markets, without losing their original philosophy. In practice, it often means translating complex ideas – such as fermentation, microbiome balance or slow, thoughtful skincare – into clear, honest messages that resonate with people in different regions, while still respecting the essence of the original Japanese approach.”
Trends Defining the Future
The Europe Time: Your work combines pharmaceutical expertise, market forecasting, and strategic development. What key trends do you believe will shape the future of the healthcare industry?
Iryna Timanyuk replied, “I believe the future of healthcare will become increasingly personalised, preventive and microbiome‑focused. Consumers are becoming more educated and are looking for solutions that support overall wellbeing rather than simply addressing symptoms. In this context, evidence‑based nutraceuticals, probiotics, postbiotics and microbiome‑aware skincare will play an even more important role.
We will also see stronger integration between scientific research, digital healthcare technologies, nutraceuticals and cosmetic innovation. Another important trend is the growing demand for transparency and evidence‑based communication. People want to understand not only what a product does, but also the science, philosophy and cultural background behind it. Companies that can combine real evidence, clear explanations and respect for the consumer will be the ones to build long‑term trust.”
Leading with Integrity, Science & Purpose
Lastly we asked, “What motivates you most in your professional journey, and what message would you like to share with aspiring healthcare professionals and entrepreneurs?”
“What motivates me most is the opportunity to bridge science, business and meaningful human impact. Having gone through war, relocation and a complete transformation of how I see dietary supplements and skincare, I feel a strong responsibility to keep this field responsible, ethical and evidence‑driven. Whether we talk about pharmaceuticals, nutraceuticals or cosmetics, the ultimate goal for me is always the same – to genuinely improve quality of life in a sustainable and conscious way.
To young professionals and entrepreneurs, I would say: never stop learning and remain intellectually honest. Question the evidence behind every product and strategy you promote, and be sure that it truly brings value to people rather than just following a trend. Long‑term trust is built through integrity, knowledge and consistency – and in healthcare, trust is the most valuable asset we have.” Iryna Timanyuk concluded
Connect with Iryna Timanyuk on LinkedIn
For more information visit Sentaku Group
Also Read:-
Dr. Christoph Guger on RecoveriX and brain tech future
Human AI Takes the Global Stage at WAICF 2026
Dr. Bachar Fakhry on crisis market psychology insight